The results showed that eight proteins (IL‐2, IL‐5, IP‐10, IL‐8, eotaxin, TNF‐α, HGF, and MIP‐1b) had higher serum levels in ESCC patients than in normal controls (Figure 1). This evidence concerns the gene IL2 and esophageal squamous cell carcinoma.